Is it time for subcategories within the atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda System for Reporting Thyroid Cytopathology? This editorial summarizes recent reports on risk stratification within the AUS/FLUS subcategory and its implications for patient management.
No takes yet. Share an insight, caveat, or question.
Nishino et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: